353 related articles for article (PubMed ID: 7813472)
21. Kinetic analysis of triple-helix formation by pyrimidine oligodeoxynucleotides and duplex DNA.
Xodo LE
Eur J Biochem; 1995 Mar; 228(3):918-26. PubMed ID: 7737194
[TBL] [Abstract][Full Text] [Related]
22. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide.
Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM
Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044
[TBL] [Abstract][Full Text] [Related]
23. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
24. Exploring cellular activity of locked nucleic acid-modified triplex-forming oligonucleotides and defining its molecular basis.
Brunet E; Alberti P; Perrouault L; Babu R; Wengel J; Giovannangeli C
J Biol Chem; 2005 May; 280(20):20076-85. PubMed ID: 15760901
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence characterization of the transcription bubble in elongation complexes of T7 RNA polymerase.
Liu C; Martin CT
J Mol Biol; 2001 May; 308(3):465-75. PubMed ID: 11327781
[TBL] [Abstract][Full Text] [Related]
26. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional inhibition of the bacteriophage T7 early promoter region by oligonucleotide triple helix formation.
Ross C; Samuel M; Broitman SL
Biochem Biophys Res Commun; 1992 Dec; 189(3):1674-80. PubMed ID: 1482373
[TBL] [Abstract][Full Text] [Related]
28. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
29. Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif.
Basye J; Trent JO; Gao D; Ebbinghaus SW
Nucleic Acids Res; 2001 Dec; 29(23):4873-80. PubMed ID: 11726697
[TBL] [Abstract][Full Text] [Related]
30. Binding of triple helix forming oligonucleotides to sites in gene promoters.
Durland RH; Kessler DJ; Gunnell S; Duvic M; Pettitt BM; Hogan ME
Biochemistry; 1991 Sep; 30(38):9246-55. PubMed ID: 1892832
[TBL] [Abstract][Full Text] [Related]
31. A direct real-time spectroscopic investigation of the mechanism of open complex formation by T7 RNA polymerase.
Sastry SS; Ross BM
Biochemistry; 1996 Dec; 35(49):15715-25. PubMed ID: 8961934
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
Mayfield C; Squibb M; Miller D
Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of inhibition of bacteriophage T7 RNA polymerase by T7 lysozyme.
Zhang X; Studier FW
J Mol Biol; 1997 May; 269(1):10-27. PubMed ID: 9192997
[TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of transcription by triple helix-forming oligonucleotides.
Duval-Valentin G; Thuong NT; Hélène C
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):504-8. PubMed ID: 1731320
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of transcription by platinated triplex-forming oligonucleotides.
Graham MK; Miller PS
J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663
[TBL] [Abstract][Full Text] [Related]
36. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
[TBL] [Abstract][Full Text] [Related]
37. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
38. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.
Campbell MA; Miller PS
Bioconjug Chem; 2009 Dec; 20(12):2222-30. PubMed ID: 19950917
[TBL] [Abstract][Full Text] [Related]
39. Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription.
Liu J; Xu R; Jin Y; Wang D
Nucleic Acids Res; 2001 Feb; 29(3):783-91. PubMed ID: 11160902
[TBL] [Abstract][Full Text] [Related]
40. Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines.
Xodo LE; Manzini G; Quadrifoglio F
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):477-88. PubMed ID: 9918112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
